News
Explore the latest stories and publications from NCATS and our partners, see upcoming events, or explore the variety of resources we provide to better understand translational science and our work.
News
Read the latest news from NCATS and its collaborators whose research is supported through the Center’s programs, or follow coverage of NCATS' translational research activities through national and local media.
Sleep-Aligned Fasting May Support Overnight Heart Health
July 9, 2026 - NCATS News
- Clinical and Translational Science Awards (CTSA) Program
Researchers found that aligning fasting with the body’s natural sleep cycle before bedtime may support cardiovascular and metabolic health.
Read Article
AMP® BGTC Announces FDA Clearance of Investigational New Drug Application for Gene Therapy Targeting Multiple Sulfatase Deficiency
July 6, 2026 - Grantee/Partner News
- Bespoke Gene Therapy Consortium (BGTC)
The FDA cleared the Investigational New Drug (IND) application for a gene therapy designed to treat children with multiple sulfatase deficiency (MSD), an ultra-rare disease.
Read ArticleHow Repurposing a Drug May Help Treat More Rare Gastrointestinal Diseases
June 29, 2026 - NCATS News
- Rare Diseases Clinical Research Network (RDCRN)
RDCRN researchers found that dupilumab — a drug used for asthma and chronic obstructive pulmonary disease — shows promise in treating eosinophilic gastritis.
Healthcare and Policy Updates, June 2026
June 15, 2026 - Media Coverage
- Our Impact on Big Data
- Our Impact on Clinical Trials
- Our Impact on Drug Discovery and Development
- Our Impact on Rare Diseases
- Our Impact on Research Operations
- Our Impact on Tools and Technologies
- Translational Science
Research Tip Sheet: Knee Arthritis, In-Hospital Addiction Help
June 12, 2026 - Grantee/Partner News
- Clinical and Translational Science Awards (CTSA) Program
New Study Shows Metformin Given During Acute COVID-19 Infection Reduced Risk of Clinician-Diagnosed Long COVID by 50%
June 11, 2026 - Grantee/Partner News
- COVID-19
People Who Use Illicit Fentanyl Consume Daily Doses Equivalent to Nearly 9,000 Milligrams of Morphine
June 10, 2026 - Grantee/Partner News
- Clinical and Translational Science Awards (CTSA) Program
Engineered Gut Bacteria Therapy Emerges as Scalable Potential Alternative to Fecal Microbiota Transplants Following Clinical Trial
June 2, 2026 - Grantee/Partner News
- Clinical and Translational Science Awards (CTSA) Program